▼

Thursday, July 25, 2019

FDA aims high in crackdown on CBD manufacturers - in-PharmaTechnologist

 By Ben Hargreaves
US FDA took aim at the ‘world’s largest cannabis’ company for making ‘unfounded claims’ about the therapeutic potential of its CBD products.
https://www.in-pharmatechnologist.com/Article/2019/07/24/FDA-sends-warning-letter-in-crackdown-on-CBD-claims?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright 

You might also be interested in:   FDA cGMP QSR GMP Online Training Courses
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.